Cite
MLA Citation
Andrew Blauvelt et al.. “Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.” Lancet, vol. 389, no. 10086, 2017, pp. 2287–2303. http://access.bl.uk/ark:/81055/vdc_100046742378.0x00002b